Business Segments · Cost of Sales

Health & Biosciences — Cost of Sales

International Flavors & Fragrances Health & Biosciences — Cost of Sales increased by 3.8% to $327.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.7%, from $298.00M to $327.00M. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementSegment
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2024
Last reportedQ1 2026May 5, 2026

How to read this metric

An increase relative to sales may indicate rising input costs or manufacturing inefficiencies.

Detailed definition

The direct costs attributable to the production of goods and services sold by the Health & Biosciences segment. This inc...

Peer comparison

Standard 'Cost of Goods Sold' (COGS) metric used across manufacturing and chemical industries.

Metric ID: iff_segment_health_biosciences_cost_of_sales

Historical Data

7 periods
 Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$286.00M$294.00M$305.00M$298.00M$311.00M$315.00M$327.00M
QoQ Change+2.8%+3.7%-2.3%+4.4%+1.3%+3.8%
YoY Change+4.2%+5.8%+3.3%+9.7%
Range$286.00M$327.00M
CAGR+9.3%
Avg YoY Growth+5.7%
Median YoY Growth+5.0%
Current Streak3 quarters growth

Frequently Asked Questions

What is International Flavors & Fragrances's health & biosciences — cost of sales?
International Flavors & Fragrances (IFF) reported health & biosciences — cost of sales of $327.00M in Q1 2026.
How has International Flavors & Fragrances's health & biosciences — cost of sales changed year-over-year?
International Flavors & Fragrances's health & biosciences — cost of sales increased by 9.7% year-over-year, from $298.00M to $327.00M.
What does health & biosciences — cost of sales mean?
The direct costs incurred to produce the goods sold by the segment.